Literature DB >> 14693726

The protein components and mechanism of eukaryotic Okazaki fragment maturation.

Hui-I Kao1, Robert A Bambara.   

Abstract

An initiator RNA (iRNA) is required to prime cellular DNA synthesis. The structure of double-stranded DNA allows the synthesis of one strand to be continuous but the other must be generated discontinuously. Frequent priming of the discontinuous strand results in the formation of many small segments, designated Okazaki fragments. These short pieces need to be processed and joined to form an intact DNA strand. Our knowledge of the mechanism of iRNA removal is still evolving. Early reconstituted systems suggesting that the removal of iRNA requires sequential action of RNase H and flap endonuclease 1 (FEN1) led to the RNase H/FEN1 model. However, genetic analyses implied that Dna2p, an essential helicase/nuclease, is required. Subsequent biochemical studies suggested sequential action of RPA, Dna2p, and FEN1 for iRNA removal, leading to the second model, the Dna2p/RPA/FEN1 model. Studies of strand-displacement synthesis by polymerase delta indicated that in a reconstituted system, FEN1 could act as soon as short flaps are created, giving rise to a third model, the FEN1-only model. Each of the three pathways is supported by different genetic and biochemical results. Properties of the major protein components in this process will be discussed, and the validity of each model as a true representation of Okazaki fragment processing will be critically evaluated in this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14693726     DOI: 10.1080/10409230390259382

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  52 in total

Review 1.  The role of DNA exonucleases in protecting genome stability and their impact on ageing.

Authors:  Penelope A Mason; Lynne S Cox
Journal:  Age (Dordr)       Date:  2011-09-23

2.  Idling by DNA polymerase delta maintains a ligatable nick during lagging-strand DNA replication.

Authors:  Parie Garg; Carrie M Stith; Nasim Sabouri; Erik Johansson; Peter M Burgers
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

3.  Direct Visualization of RNA-DNA Primer Removal from Okazaki Fragments Provides Support for Flap Cleavage and Exonucleolytic Pathways in Eukaryotic Cells.

Authors:  Bochao Liu; Jiazhi Hu; Jingna Wang; Daochun Kong
Journal:  J Biol Chem       Date:  2017-02-03       Impact factor: 5.157

Review 4.  Polymerase dynamics at the eukaryotic DNA replication fork.

Authors:  Peter M J Burgers
Journal:  J Biol Chem       Date:  2008-10-03       Impact factor: 5.157

5.  Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases eta and REV1.

Authors:  Parie Garg; Peter M Burgers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

6.  The MPH1 gene of Saccharomyces cerevisiae functions in Okazaki fragment processing.

Authors:  Young-Hoon Kang; Min-Jung Kang; Jeong-Hoon Kim; Chul-Hwan Lee; Il-Taeg Cho; Jerard Hurwitz; Yeon-Soo Seo
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

7.  WRN helicase unwinds Okazaki fragment-like hybrids in a reaction stimulated by the human DHX9 helicase.

Authors:  Prasun Chakraborty; Frank Grosse
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

8.  Regulation of interactions with sliding clamps during DNA replication and repair.

Authors:  Francisco J López de Saro
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

9.  TbPIF5 is a Trypanosoma brucei mitochondrial DNA helicase involved in processing of minicircle Okazaki fragments.

Authors:  Beiyu Liu; Jianyang Wang; Gokben Yildirir; Paul T Englund
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

Review 10.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.